Elanco Animal Health Cash Flow from Operating Activities 2016-2024 | ELAN
Elanco Animal Health annual/quarterly cash flow from operating activities history and growth rate from 2016 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
- Elanco Animal Health cash flow from operating activities for the quarter ending March 31, 2024 was $0.002B, a 101.38% decline year-over-year.
- Elanco Animal Health cash flow from operating activities for the twelve months ending March 31, 2024 was $303M, a 69.58% decline year-over-year.
- Elanco Animal Health annual cash flow from operating activities for 2023 was $0.271B, a 40.04% decline from 2022.
- Elanco Animal Health annual cash flow from operating activities for 2022 was $0.452B, a 6.42% decline from 2021.
- Elanco Animal Health annual cash flow from operating activities for 2021 was $0.483B, a 1278.05% decline from 2020.
| Elanco Animal Health Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2023 | $271 |
| 2022 | $452 |
| 2021 | $483 |
| 2020 | $-41 |
| 2019 | $224 |
| 2018 | $487 |
| 2017 | $174 |
| 2016 | $156 |
| 2015 | $7 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $8.737B | $4.417B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $17.770B | 10.75 |
| Quest Diagnostics (DGX) | United States | $15.772B | 16.30 |
| DaVita (DVA) | United States | $12.902B | 16.03 |
| Encompass Health (EHC) | United States | $8.698B | 22.26 |
| Chemed (CHE) | United States | $8.393B | 26.01 |
| Option Care Health (OPCH) | United States | $5.183B | 19.62 |
| RadNet (RDNT) | United States | $4.332B | 90.21 |
| Amedisys (AMED) | United States | $2.979B | 21.10 |
| Astrana Health (ASTH) | United States | $2.321B | 31.39 |
| LifeStance Health (LFST) | United States | $2.129B | 0.00 |
| Addus HomeCare (ADUS) | United States | $1.879B | 26.89 |
| U.S Physical Therapy (USPH) | United States | $1.546B | 41.36 |
| Pennant (PNTG) | United States | $0.707B | 37.37 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.502B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.263B | 0.00 |
| Daxor (DXR) | United States | $0.041B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.025B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.021B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.020B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| Ontrak (OTRK) | United States | $0.012B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.003B | 0.00 |